Dabuzalgron

CAS : 219311-44-1

Ref. 3D-UIA31144

Informations sur le produit

• Nom: Dabuzalgron
• Synonymes: Methanesulfonamide, N-[6-chloro-3-[(4,5-dihydro-1H-imidazol-2-yl)methoxy]-2-methylphenyl]-, N-[6-Chloro-3-[(4,5-dihydro-1H-imidazol-2-yl)methoxy]-2-methylphenyl]methanesulfonamide, R 450
• CAS: 219311-44-1

Description

Dabuzalgron is a drug that acts as an inhibitor of mitochondrial functions. It is used in clinical studies to treat symptoms of menopause, including hot flashes and night sweats. Dabuzalgron has been shown to increase uptake in women by up to 30%. This drug also increases the mitochondrial function in cells, which is necessary for effective chemotherapy. Dabuzalgron has been shown to have physiological effects, such as pro-apoptotic protein and apoptotic effect on bladder cancer cells. It has also been shown to decrease insulin-stimulated glucose levels and protein synthesis in fat cells, leading to decreased cancer rates. Dabuzalgron has also been shown to be beneficial for cardiac health by decreasing fatty acid production and inhibiting the formation of heart disease-causing plaques.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 317.79 g/mol
• Formule: C₁₂H₁₆ClN₃O₃S
• Degré de pureté: Min. 95%